Global Tuberculosis Diagnosis and Treatment Industry to 2028 – by Diagnosis, Drugs, End User and Region – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The report “Global Tuberculosis Diagnosis and Treatment Market 2022-2028” has been added to from ResearchAndMarkets.com offer.

The global tuberculosis diagnosis and treatment market is expected to grow at a substantial CAGR of 6.1% during the forecast period.

Companies cited

  • Abbott Laboratories Inc.

  • Akonni Biosystems, Inc.

  • Becton Dickinson and Co.

  • Biochemicals and Synthetics Pvt Ltd

  • Biomerieux SA

  • Cepheid Inc.

  • Eiken Chemical Co. Ltd.

  • Epistem Ltd.

  • F. Hoffmann-LA Roche AG

  • GlaxoSmithKline PLC

  • Hain Lifescience GmbH

  • Hologic Inc.

  • Johnson & Johnson Services, Inc.

  • LabatecPharma SA

  • Lupine Pharmaceuticals Inc.

  • Novartis AG

  • Otsuka Pharmaceutical Co. Ltd.

  • Perkin Elmer Inc.

  • QiagenGmbH

  • Sanofi SA

  • ThermoFisher Scientific, Inc.

The increasing technological advancements in the field of tuberculosis are driving the tremendous growth of the market. Due to various technological advancements, new diagnostic solutions are being made available to diagnose these diseases which also provide accuracy and speed.

The molecular diagnostic tests recommended by WHO are LPA and Xpert MTB/RIF and the initial diagnosis of tuberculosis is made by rapid molecular tests (eg Xpert MTB/RIF) and not by conventional microscopy methods. Light-emitting diode fluorescence microscopy is the recommended method for microscopy at all laboratory levels. Some of these WHO-approved tests can detect mycobacterial genetic mutations associated with TB drug resistance, enabling clinicians to tailor effective TB treatment and directly drive the market.

For example, in 2022, the WHO announced a new class of tests to diagnose TB infection called Tuberculosis Antigen-Based Skin Tests (TBST). These tests represent an alternative to the tuberculin skin test (TST) and interferon gamma release tests (IGL).

The global tuberculosis diagnosis and treatment market is segmented on the basis of technology, product, application, and end-user. Technology-based, the market is sub-categorized into cell-based and bead-based. On the basis of product, the market is divided into reagents and consumables, components, platforms, services, software and accessories. Based on applications, the market is sub-segmented into research and clinical applications and diagnostic applications. Based on end-user, the market is sub-segmented into hospitals, research institutes, clinical testing laboratories, and others.

The hospital segment is expected to grow at the fastest rate as hospitals help patients to take medical assistance under the observation of experienced surgeons. Growing number of cancer patients along with rising awareness about various benefits and facilities provided in hospitals are considered as a prime factor supporting the growth of the hospital segment.

Geographically, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. North America dominates the market and is expected to maintain its presence during the forecast period. The growth can be attributed to different factors such as different initiatives of governments and non-profit organizations. According to the UNDP, by 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, waterborne diseases and other communicable diseases. This will therefore boost the market for the diagnostics market.

The report covers

  • Comprehensive research methodology of the global Tuberculosis Diagnosis and Treatment Market.

  • This report also includes a detailed and comprehensive overview of the market with key insights from analysts.

  • A comprehensive analysis of macro and micro factors influencing the market guided by key recommendations.

  • Analysis of regional regulations and other government policies impacting the global Tuberculosis Diagnosis and Treatment market.

  • Overview of market determinants driving the global tuberculosis diagnosis and treatment market.

  • Detailed and extensive market segments with the regional breakdown of forecast revenue.

  • Detailed profiles and recent developments of market players.

Main topics covered:

1. Summary of the report

2. Overview and Market Overview

2.1. Report scope

2.2. Analyst overview and current market trends

2.2.1. Main findings

2.2.2. Recommendations

2.2.3. Conclusion

3. Competitive landscape

3.1. Key business analysis

3.1.1. Otsuka Pharmaceuticals Co. Ltd.

3.1.1.1. Insight

3.1.1.2. Financial analysis

3.1.1.3. SWOT analysis

3.1.1.4. RECENT DEVELOPMENTS

3.1.2. Johnson & Johnson Services Inc.

3.1.2.1. Insight

3.1.2.2. Financial analysis

3.1.2.3. SWOT analysis

3.1.2.4. RECENT DEVELOPMENTS

3.1.3. Abbott Laboratories, Inc.

3.1.3.1. Insight

3.1.3.2. Financial analysis

3.1.3.3. SWOT analysis

3.1.3.4. RECENT DEVELOPMENTS

3.1.4. Becton, Dickinson and Co.

3.1.4.1. Insight

3.1.4.2. Financial analysis

3.1.4.3. SWOT analysis

3.1.4.4. RECENT DEVELOPMENTS

3.1.5. ThermoFisher Scientific, Inc.

3.1.5.1. Insight

3.1.5.2. Financial analysis

3.1.5.3. SWOT analysis

3.1.5.4. RECENT DEVELOPMENTS

3.2. Key strategic analysis

3.3. Impact of Covid-19 on key players

4. Market segmentation

4.1. Global Tuberculosis Diagnosis and Treatment Market, By Diagnosis

4.2. Global Tuberculosis Diagnosis and Treatment Market, By Drugs

4.3. Global Tuberculosis Diagnosis and Treatment Market, By End User

5. Regional analysis

6. Company Profiles

For more information on this report visit https://www.researchandmarkets.com/r/y0zl7r

Comments are closed.